Skip to main content
. 2022 Dec 22;12(1):86. doi: 10.3390/jcm12010086

Figure 1.

Figure 1

Study flow chart. b/tsDMARDs, biologic/targeted synthetic disease-modifying antirheumatic drugs; CMUH, China Medical University Hospital; DNA, deoxyribonucleic acid; HBV, hepatitis B virus; HBsAg, hepatitis B virus surface antigen; RA, rheumatoid arthritis; TCVGH, Taichung Veterans General Hospital.